Abstracts

MULTI-OMICS ANALYSIS OF GUT MICROBIOME AND ATHEROSCLEROSIS IN WOMEN LIVING WITH HIV

Background: Alterations in gut microbiota have been implicated in HIV infection and cardiovascular disease. However, how gut microbial alterations relate to host inflammation and metabolite profiles, and their relationships with atherosclerosis, have not been well-studied, especially in the context of HIV infection. Methods: We examined associations of gut microbial species and functional components measured by…

CTL EPITOPES FROM STRUCTURALLY IMPORTANT HIV PROTEINS ARE IDENTIFIED IN REBOUND HIV

Background: During an analytic treatment interruption (ATI), the elimination of HIV-infected cells by HIV-specific cytotoxic CD8 T cells (CTLs) is required to control viral infection. However, unless treatment is initiated during acute infection, the HIV reservoir becomes dominated by CTL escape variants resistant to immune response. To address this issue, we applied a novel IMmunoinformatics…

SMALL MOLECULE INHIBITOR FOR BLOCKING SARS-CoV-2 ENTRY

Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel and highly pathogenic coronavirus and is the causative agent of COVID-19, an ongoing pandemic that has posed a serious threat to public health and global economy. Thus, there is a pressing need for therapeutic interventions that target essential viral proteins and regulate virus spread and…

DECREASED HIV-SPECIFIC POLYFUNCTIONAL RESPONSES FOLLOWING DIPYRIDAMOLE TREATMENT

Background: Decreases in extracellular adenosine (ADO) production are associated with increased inflammation and immune activation in ART-treated people living with HIV (PWH). We previously showed that 12 weeks (w) of treatment with dipyridamole (DP), which increases extracellular ADO levels, decreased CD8+ T cell activation in PWH. Here, we investigated if the decrease in activation also…

ENHANCED HIV-INDUCED LINEAGE TRACING REPORTER SYSTEM REVEALS EARLY LATENCY PHENOTYPE

Background: Current Human Immunodeficiency Virus (HIV) treatments effectively suppress viral replication but fail to cure patients of infection due to the persistence of latently infected cells. Latently infected cells are nearly indistinguishable from uninfected cells and evade clearance by the host immune system. Current primary cell models of latency utilize in vitro infection often employ…